Therefore, the lower the level of PD-L1, the less the expected therapeutic outcome. in a wide range of malignancies, including those where optimal treatment is
Therefore, the lower the level of PD-L1, the less the expected therapeutic outcome. in a wide range of malignancies, including those where optimal treatment is